Crystal structures of agonist-bound human cannabinoid receptor CB<sub>1</sub>.

Hua, Tian; Vemuri, Kiran; Nikas, Spyros P; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan et al. · Nature · 2025

basic_science · Level V

Where this comes from

Abstract

Cannabinoid receptor 1 (CB<sub>1</sub>) is the primary target of the partial agonist Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC), the psychoactive constituent of marijuana<sup>1</sup>. Here we report two agonist-bound crystal structures of human CB<sub>1</sub> in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB<sub>1</sub>-agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state<sup>2</sup>, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe200<sup>3.36</sup> and Trp356<sup>6.48</sup> (where the superscripts denote Ballesteros-Weinstein numbering<sup>3</sup>) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB<sub>1</sub> and provide a molecular basis for predicting the binding modes of Δ<sup>9</sup>-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB<sub>1</sub> seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.

Medical subject headings